Concentra Group Holdings Parent, Inc.
CON Healthcare Medical Care Facilities
Concentra Group Holdings Parent, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 13.9% from fiscal 2024. In the quarter to June 2026, revenue grew 10.0%, EPS grew 45.7%, free cash flow grew 91.6% and total debt fell 5.54%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
Follow CON
Concentra Group Holdings Parent, Inc. (CON) Altman Z-score
Concentra Group Holdings Parent, Inc.'s Altman Z-score for fiscal 2025 is 1.85, in the grey zone (1.81–2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 1.85 | 0.02 |
| FY2024 | 1.83 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.02 | — | 0.02 | |
| Retained earnings / total assets | 0.05 | — | 0.07 | |
| EBIT / total assets | 0.12 | — | 0.39 | |
| Market value of equity / total liabilities | 1.03 | — | 0.62 | |
| Sales / total assets | 0.76 | — | 0.76 | |
| Altman Z-score | Grey zone | 1.85 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Grey zone | 1.23 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| CHE Chemed Corporation compare | 11.7× |
| GRDN Guardian Pharmacy Services, Inc. compare | 10.3× |
| NHC National HealthCare Corporation compare | 5.0× |
| OPCH Option Care Health, Inc. compare | 3.9× |
| LFST LifeStance Health Group, Inc. compare | 2.6× |
| PACS PACS Group, Inc. compare | 2.0× |
| CON Concentra Group Holdings Parent, Inc. | 1.8× |
| AVAH Aveanna Healthcare Holdings Inc. compare | 1.5× |
| ACHC Acadia Healthcare Company, Inc. compare | 0.9× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets